HTB: issue 5 online (14 March 2018): Special CROI issue
14 March 2018. Related: News.
This special edition of HTB includes the first reports from CROI 2018, with additional reports following in subsequent issues.
Important themes this year included cure-related research, TB coinfection, PrEP and new antiretroviral drugs.
As usual, webcasts and conference material are already online.
Also, news that after more than a decade in development, the monoclonal antibody ibalizumab has been approved in the US as a treatment for multidrug resistant HIV.